BNO 5.26% 20.0¢ bionomics limited

Ann: Ceasing to be a substantial holder, page-15

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 21 Posts.
    lightbulb Created with Sketch. 2
    Just a question, but have you compared the CEO's pay to other Biotech companies like Starpharma?

    BNO's CEO remuneration is almost half that of Starpharma's CEO. I'm not a fan of giving money away to executive's but its very different to have BNO CEO materially underpaid vs peers and then to want further cuts
    Last edited by Ratattack23: Spelling Errors 02/07/18
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.